Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

“The amount of inflammation is significantly elevated in the follicular phase, or first half, of the menstrual cycle in female patients with sickle cell disease,” said lead researcher Dr ...